| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/28/2013 | US20130052132 Method for Producing Radioactively Labeled Polypeptide |
| 02/28/2013 | US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use |
| 02/28/2013 | US20130052130 Branched Discreet PEG Constructs |
| 02/28/2013 | US20130052129 Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid |
| 02/28/2013 | US20130052128 Upar Binding Agents and Methods of Use Thereof |
| 02/28/2013 | CA2846122A1 Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (pde10a) in mammals |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560690A1 Cyclopentapeptide derivatives and uses thereof |
| 02/27/2013 | EP2560687A2 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 02/27/2013 | CN102160894B Benzamide analog mediated brain-targeting delivery system |
| 02/27/2013 | CN101194855B Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor |
| 02/26/2013 | US8383772 Ang-(1-7) receptor agonist |
| 02/26/2013 | US8383578 Peptides, derivatives and analogs thereof, and methods of using same |
| 02/26/2013 | US8383083 Polymer precursors of radiolabeled compounds, and methods of making and using the same |
| 02/26/2013 | US8383082 Pharmaceutical composition of nanoparticles |
| 02/26/2013 | US8383081 Anti-CD74 immunoconjugates and methods of use |
| 02/26/2013 | CA2536256C Targeting of tumor vasculature using radiolabelled antibody l19 against fibronectin ed-b |
| 02/26/2013 | CA2358570C Protonated/acidified nucleic acids and methods of use |
| 02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
| 02/21/2013 | WO2013023795A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| 02/21/2013 | US20130045165 4-fluoro-4-arylpiperdin-1-yl derivatives as mu opioid function moderators |
| 02/21/2013 | US20130045164 Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 02/21/2013 | US20130045163 Treatment of metastatic tumors |
| 02/21/2013 | US20130045162 Delivery system for specifically targeting cancer cells and method of use thereof |
| 02/21/2013 | US20130045161 Methods and compositions for targeted imaging |
| 02/21/2013 | US20130045160 Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance |
| 02/21/2013 | CA2845477A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi |
| 02/20/2013 | CN101573384B Antibodies and immunoconjugates and uses therefor |
| 02/19/2013 | US8378072 solid phase synthesis of directed epitope peptide mixtures useful in the modulation of unwanted immune responses, such process defined by a set of rules regarding the identity and the frequency of occurrence of amino acids that substitute a base or native amino acid of a known epitope. |
| 02/19/2013 | US8378071 Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/19/2013 | US8377868 Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377418 Process for preparing thermosensitive (poly(ethylene oxide) poly(propylene oxide)) derivatives that can be used to functionalize chitosan |
| 02/19/2013 | CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
| 02/14/2013 | WO2013022797A1 Radiolabeled prostate specific membrane antigen inhibitors |
| 02/14/2013 | US20130039853 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/14/2013 | US20130039852 Methods of targeting cells for diagnosis and therapy |
| 02/14/2013 | US20130039851 Stabilizing Alkylglycoside Compositions and Methods Thereof |
| 02/14/2013 | US20130039850 Heterologous antibodies which bind human cd4 |
| 02/14/2013 | US20130039849 Adenocarcinoma specific antibody sam-6, and uses thereof |
| 02/14/2013 | US20130039848 Fluorescent silica-based nanoparticles |
| 02/14/2013 | US20130039847 Liposomes for pulmonary administration |
| 02/14/2013 | CA2844151A1 Radiolabeled prostate specific membrane antigen inhibitors |
| 02/13/2013 | EP2556372A1 Synthesis of 18f-labeled tracers in hydrous organic solvents |
| 02/13/2013 | EP2555797A1 Tnf- binding proteins |
| 02/13/2013 | CN202724446U High flexibility radioactive particle |
| 02/13/2013 | CN102924598A Anti-alphavbeta6 antibodies |
| 02/13/2013 | CN102921022A Drug-loaded nanoparticle with nuclide imaging, fluorescence imaging and MRI functions, and preparation method and application thereof |
| 02/13/2013 | CN102430133B Radioactive medicine synthesis module capable of being repeatedly used in same day |
| 02/13/2013 | CN102065905B Methods for radiolabelling synthetic polymers |
| 02/13/2013 | CN101460849B Diagnostic agent and therapeutic agent for pancreatic cancer |
| 02/12/2013 | US8372800 Albumin-free factor VIII formulations |
| 02/12/2013 | US8372380 In vivo imaging of sulfotransferases |
| 02/12/2013 | US8372379 Technetium-99m (I) tricarbonyl complexes with tridentate chelators for myocardium imaging |
| 02/12/2013 | CA2545362C Assembly of gas-filled microvesicle with active component for contrast imaging |
| 02/12/2013 | CA2498936C Structurally rigid dopamine d3 receptor selective ligands and process for making them |
| 02/12/2013 | CA2487908C Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 02/07/2013 | WO2013019975A1 Compositions and methods of treating cancer |
| 02/07/2013 | WO2013019730A1 Antibodies to tip-1 and grp78 |
| 02/07/2013 | WO2012143713A3 Radioactive solutions for treating cancer |
| 02/07/2013 | US20130034497 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 02/07/2013 | US20130034496 Positron emission tomography tracer |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130034494 Radiolabeled prostate specific membrane antigen inhibitors |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | US20130034492 Class I Anti-CEA Antibodies and Uses Thereof |
| 02/06/2013 | EP2552891A1 Tricyclic indole derivatives as pbr ligands |
| 02/06/2013 | EP2552494A1 Lipophilic cationic probe for pet- imaging |
| 02/06/2013 | EP2552443A1 Improved treatment of renal cell carcinoma |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102911256A Radioactive label polypeptide coordination complex and preparation method and application thereof |
| 02/05/2013 | US8367037 Anti-CD74 immunoconjugates and methods of use |
| 02/05/2013 | CA2558738C Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 02/05/2013 | CA2474142C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 02/05/2013 | CA2340091C Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 01/31/2013 | US20130030168 Device For Synthesis Of Radiopharmaceutical Products |
| 01/31/2013 | US20130028838 F18-tyrosine derivatives for imaging bone metastases |
| 01/31/2013 | US20130028837 Contrast agents for myocardial perfusion imaging |
| 01/31/2013 | US20130028836 Chlorotoxin polypeptides and conjugates and uses thereof |
| 01/31/2013 | US20130028835 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 01/30/2013 | EP2549999A1 Azo compounds reducing formation and toxicity of amyloid beta aggregation intermediates |
| 01/30/2013 | CN102898470A Novel organic phosphine compound and preparation method and application thereof |
| 01/30/2013 | CN102898421A Pyridazinone compound containing polyethyleneglycol (PEG) modified benzyl triazolyl and preparation method and application thereof |
| 01/30/2013 | CN102614536B Cell apoptosis imaging medicament 68Ga-NOTA-Duramycin and preparation method thereof |
| 01/30/2013 | CN102335442B Urea [14C] capsules and micro-packaging method thereof |
| 01/30/2013 | CN102333548B Methods and compositions for protein labelling |
| 01/30/2013 | CN102180949B Polypeptide capable of specifically combining vessel endothelial growth factor and application thereof |
| 01/30/2013 | CN101360731B Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins |
| 01/30/2013 | CN101258166B Antibody combining with STEAP-1 protein and deriving molecule thereof |
| 01/29/2013 | US8361969 Designer cyclic peptides—HIV gp120 antagonists and their applications |
| 01/29/2013 | US8361464 Anthracycline-Antibody Conjugates for Cancer Therapy |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | US8361440 Imaging method and device for carrying out said method |
| 01/29/2013 | US8361439 Pharmaceutical composition of nanoparticles |
| 01/29/2013 | US8361437 Multimodal nanoparticles for non-invasive bio-imaging |
| 01/24/2013 | WO2013012817A1 Methods and compositions for drying in the preparation of radiopharmaceuticals |
| 01/24/2013 | WO2013012754A1 Boron-based dual imaging probes, compositions and methods for rapid aqueous f-18 labeling, and imaging methods using same |
| 01/24/2013 | WO2012157920A3 Radioactive compound synthesis system having temperature-control unit |
| 01/24/2013 | WO2012157898A3 Apparatus and method for synthetizing synthesizing f-18 labeled radioactive pharmaceuticals |